Clinical Trials for Scleroderma

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

NCT ID: NCT05925803

The DAISY clinical trial is studying the effectiveness and safety of a new treatment called anifrolumab for adults with systemic sclerosis, also known as scleroderma. This trial is specifically aim...

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT ID: NCT06991114

This clinical trial is studying a new treatment called AlloNK, which uses natural killer (NK) cells derived from umbilical cord blood, combined with a medication called rituximab. The trial is aime...

DR-0201 in Subjects With Autoimmune Diseases

NCT ID: NCT06647069

This clinical trial, called DR-0201, is looking at a new treatment for people with certain autoimmune diseases, including systemic lupus erythematosus (SLE), cutaneous lupus, Sjögren's syndrome, an...

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT ID: NCT01793168

The Coordination of Rare Diseases at Sanford (CoRDS) is a clinical trial aimed at creating a large, centralized registry for individuals affected by rare diseases. This registry helps connect patie...

RENEW-AI: Personalizing Scleroderma Management With an AI Health Coach

NCT ID: NCT06999226

Platform Clinical Study for Conquering Scleroderma

NCT ID: NCT06195072

The "Platform Clinical Study for Conquering Scleroderma" is a clinical trial designed to investigate new treatments for patients suffering from Interstitial Lung Disease (ILD) caused by scleroderma...

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT ID: NCT06328777

The RESET-SSc clinical trial is studying a new treatment called CABA-201, which is a type of therapy that modifies a patient’s own immune cells to help fight systemic sclerosis (also known as scler...

Evaluating Tools to Communicate Scleroderma Research Results to Patients

NCT ID: NCT06373263

This clinical trial is focused on finding the best ways to share research results about scleroderma, a rare autoimmune disease, with patients. Researchers know it’s important to keep patients infor...

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

NCT ID: NCT06880627

The Brain Boost Program is a clinical trial designed to see if an 8-week online educational group can help improve thinking skills and overall well-being in people with systemic sclerosis, also kno...

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

NCT ID: NCT04265144

This clinical trial is studying systemic sclerosis (SSc), a rare disease that affects the skin and internal organs by causing thickening and hardening of tissues. The goal is to better understand h...

Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People with Systemic Sclerosis

NCT ID: NCT06772896

This clinical trial is studying how people with systemic sclerosis (also known as scleroderma) respond to questions about physical symptoms when they are also being asked about feelings of depressi...

Rheumatology Patient Registry and Biorepository

NCT ID: NCT04402086

The Rheumatology Patient Registry and Biorepository is a clinical trial aimed at improving our understanding of various rheumatic diseases, including conditions like rheumatoid arthritis, lupus, an...

Elastography Ultrasound in Localized Scleroderma (Morphea) Study

NCT ID: NCT06847750

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

NCT ID: NCT06843239

The TibuSURE trial is a clinical study looking at a new treatment called tibulizumab for people with systemic sclerosis (also known as scleroderma). This condition causes hardening and tightening o...

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

NCT ID: NCT03276923

The Maternal Autoimmune Disease Research Alliance (MADRA) Registry is a clinical study based at Duke University that focuses on understanding how autoimmune diseases affect pregnant women and their...

Skeletal Muscle Function in Interstitial Lung Disease

NCT ID: NCT03800017

This clinical trial is studying how muscle function affects breathing and exercise in people with interstitial lung disease (ILD), which includes conditions like idiopathic pulmonary fibrosis and h...

Ultrasound and Electrophysiology Study of Hand in Systemic Sclerosis Patients and Contributors of Hand Dysfunction

NCT ID: NCT06776575

This clinical trial is focused on understanding how systemic sclerosis, a condition that can cause thickening and hardening of the skin, affects hand function and overall quality of life for patien...

Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases

NCT ID: NCT06763783

Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

NCT ID: NCT04610788

This clinical trial is looking to understand why some people with scleroderma develop pulmonary arterial hypertension (PAH), which is high blood pressure in the lungs, and heart failure. It's also ...

UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma

NCT ID: NCT04875078